The eukaryotic cytoskeleton is a vulnerable target of many microbial pathogens during the course of infection. Rearrangements of host cytoskeleton benefi t microbes in various stages of their infection cycle such as invasion, motility, and persistence. Bacterial pathogens deliver a number of effector proteins into host cells for modulating the dynamics of actin and microtubule cytoskeleton. Alteration of the actin cytoskeleton is generally achieved by bacterial effectors that target the small GTPases of the host. Modulation of microtubule dynamics involves direct interaction of effector proteins with the subunits of microtubules or recruiting cellular proteins that affect microtubule dynamics. This review will discuss effector proteins from animal and human bacterial pathogens that either destabilize or stabilize host microtubules to advance the infectious process. A compilation of these research fi ndings will provide an overview of known and unknown strategies used by various bacterial effectors to modulate the host microtubule dynamics. The present review will undoubtedly help direct future research to determine the mechanisms of action of many bacterial effector proteins and contribute to understanding the survival strategies of diverse adherent and invasive bacterial pathogens.
Introduction
The cytoskeleton is a cytoplasmic scaffold that determines cell shape, enables cell movement, and plays an essential role in intracellular organelle transport and cell division. The cytoskeleton network consists of three types of protein fi laments: actin fi laments, intermediate fi laments, and microtubules. The eukaryotic cytoskeleton is targeted by a variety of bacterial and viral pathogens during the course of infection, and dynamic changes of the cytoskeleton infl uence the interaction of microbial pathogens with the host cells. Consequently, successful microbial pathogens modulate cytoskeleton dynamics to facilitate adherence to the cells, invasion, intraand intercellular traffi cking, and to prevent intracellular killing (1 -6) . Microbial pathogens deliver a number of effector proteins to the host cells to rearrange the cytoskeleton to benefi t the infection process. These effector proteins essentially target small GTPases to modulate the dynamics of the actin cytoskeleton of host cells (3, 7 -11) . Rearrangement of the actin cytoskeleton by pathogenic microorganisms has been extensively reviewed elsewhere (3, 8, 10, 12 -19) . This review will focus on modulation of host microtubule dynamics by pathogenic bacteria.
Microtubules are essential components of the eukaryotic cytoskeleton composed of heterodimers of α -and β -tubulin. Tubulin dimers polymerize to form a microtubule that consists of 13 linear protofi laments assembled around a hollow core (20, 21) . Microtubules are polar structures with a fastgrowing plus end and a slow-growing minus end, and this polarity determines the direction of movement along microtubules (22, 23) . Important to cell function, microtubules are dynamic structures that undergo continual assembly and disassembly within the cell (24, 25) . Many bacterial pathogens modulate this microtubule dynamics by employing virulence proteins to promote infection (Table 1 ) . This review will discuss various bacterial effectors that destabilize or stabilize host microtubule networks.
Destabilization of host microtubule cytoskeleton by bacterial pathogens
Destabilization of host microtubules is a common strategy adopted by various bacterial pathogens ( Figure 1 ). Microtubule destabilization benefi ts these pathogens in many ways, including the free movement of pathogens through the cytoplasm and modulation of actin cytoskeleton through the activation of small GTPases. Rearrangement of the actin cytoskeleton facilitates formation of membrane ruffl es and pseudopodia that promotes bacterial invasion and movement. Examples of major bacterial effectors that destabilize microtubule networks are discussed below. using its type III secretion system (T3SS), and intracellular VirA modulates the cytoskeleton dynamics to facilitate bacterial entry and intracellular movement (27, 28) . Shigella spp. defi cient in the VirA gene are defective in intracellular movement and present an attenuated phenotype in a mouse model of infection (29) . Studies have established that the VirA effector protein modulates host microtubule dynamics by acting as a destabilization factor (29) . Shigella destroys the microtubule network in the infected cells and creates a tunnel through which the bacteria move smoothly. Infection Figure 1 Bacterial effector proteins that destabilize host microtubules. The mechanism of action of effector proteins that has been demonstrated or hypothesized is illustrated. The possible benefi ts of host microtubule destruction for the pathogen have also been depicted in the fi gure. studies using mutant bacteria indicated that these properties are attributed to the VirA protein of Shigella . VirA interacts with the subunits of the microtubule through an N-terminal domain that is located between amino acid residues 224 and 315 (28) . VirA can effi ciently inhibit microtubule polymerization and induce depolymerization of assembled microtubules in a dose-dependent manner (28) . However, the mechanism whereby VirA induces microtubule destabilization remained controversial. More recently, VirA was reported as a cysteine protease that specifi cally targets the α -subunit of the tubulin heterodimer (29) . VirA is capable of degrading purifi ed human α -tubulin, and the protease activity is sensitive to the protease inhibitors leupeptin and cystatin C. Mutation studies identifi ed the catalytic cysteine residue at the N-terminus of VirA (C34), and its mutation to serine (VirAC34S) affects the activity of the protein (29) . VirAC34S does not exhibit microtubule disruption in COS-7 cells, and Shigella expressing the respective mutant presented a defective intracellular movement (29) . However, experimental data from two independent structural and functional studies contradicted the identifi ed VirA mechanism of action (30, 31) . The elucidated crystal structure of VirA reveals that it harbors two independently folded domains that resemble the letter ' V ' (30, 31) . VirA represents a novel protein fold and does not show any signifi cant structural homology to papain-like cysteine proteases as indicated by previous biochemical assays. However, the N-terminal domain of VirA exhibits limited similarity to the inhibitors of cysteine proteases. The putative active site of VirA that contains the catalytic residue Cys34 appears disordered in the crystal structure. Structural analysis also pointed out that the N-terminal domain comprising the 224 -315 amino acid region of VirA is very likely involved in dimer formation rather than tubulin interaction (30, 31) . Nevertheless, there are confl icting reports on the existence of VirA as a monomer or dimer. In contrast to the previous report (29) , others could not identify any obvious proteolytic activity or microtubule depolymerization properties by purifi ed VirA protein (30, 31) . VirA may act as a scaffold for a host papain-like cysteine protease, or recruits an unidentifi ed microtubule-destabilizing protein to facilitate the microtubule destruction.
In addition to creating a tunnel for bacterial movement by destroying microtubule networks, VirA has the ability to induce membrane ruffl es in various mammalian cells. VirAinduced membrane ruffl es are reported to be mediated by the activation of the small GTPase Rac1. It has been hypothesized that microtubule regrowth after its depolymerization may activate Rac1, resulting in the development of membrane ruffl es and lamellipodial protrusions that promote bacterial entry into host cells (28) .
EspG of Escherichia coli
Enteropathogenic E. coli (EPEC) is a bacterial pathogen that causes gastroenteritis in humans (32) . EPEC adheres to the gastrointestinal mucosa and forms attaching and effacing lesions that are characterized by localized destruction of the gastric microvillus brush border, intimate adherence of bacteria to epithelial cells, and cytoskeleton reorganization (32 -34) . EPEC injects a battery of effector proteins into intestinal epithelial cells through its T3SS to subvert the host cell processes to benefi t the extracellular bacterium (33, 35) . EPEC secretes effector proteins, EspG and EspG2, to destabilize microtubules. Importantly, EspG and EspG2 share a striking similarity (40 % and 38 % , respectively) to the VirA protein of Shigella , which is also a microtubule-destabilizing protein (36) . There is a 62 % similarity between EspG and EspG2 (36) . Interestingly, E. coli EspG as well as EspG2 can restore the intracellular persistence of the Shigella VirA mutant, indicating a functional level similarity of EspG/EspG2 and VirA (36) . In vitro infection studies using EspG mutant EPEC did not indicate any observable attenuated phenotype, whereas in vivo studies using a rabbit model of diarrhea presented with attenuated gut colonization by an EspG mutant (36) .
Wild-type EPEC caused localized microtubule destruction beneath the site of adherence (37) . Infection studies using mutant EPEC demonstrate that microtubule depletion is attributed to the EspG and EspG2 or orf3 genes. However, a single mutant of EspG did not exhibit microtubule destruction due to the functional redundancy of EspG and EspG2, whereas a double mutant was defective in microtubule depletion (37) . Both EspG and EspG2 are capable of binding tubulins but not Taxol-stabilized microtubules (38) . In vitro studies also demonstrate that EspG and EspG2 can effi ciently inhibit microtubule polymerization as well as trigger the destabilization of polymerized microtubules (38) . The exact mechanism of EspG/EspG2-mediated microtubule destruction remains unknown. Given the high similarity of VirA and EspG/EspG2, a cysteine protease activity has been proposed as the mechanism of microtubule destruction by EspG/EspG2. However, the protease activity of EspG/EspG2 has not been demonstrated. An alternative hypothesis suggests that EspG/ EspG2 acts similarly to the microtubule-destabilizing protein, stathmin, which sequesters tubulins and reduces the concentration of tubulin available for microtubule assembly (38 -40) .
Escherichia coli is an extracellular bacterium, and how EspG/EspG2-induced microtubule destruction may benefi t the pathogen remains largely unknown. EspG/EspG2-induced microtubule destruction triggers the release and activation of a microtubule-associated RhoA-specifi c guanine nucleotide exchange factor, GEF-H1. Activated GEF-H1 in turn activates a RhoA-ROCK signaling pathway and induces actin stress fi ber formation (38) . GEF-H1 associates with the epithelial tight junctions and regulates the paracellular permeability by reorganizing the actin cytoskeleton (41) . Therefore, it is assumed that the microtubule destruction by EspG/EspG2 leads to actin rearrangements and increased paracellular permeability, which contributes to EPEC-induced diarrhea.
EspG of Citrobacter
Citrobacter rodentium is a murine attaching and effacing pathogen that causes mild diarrhea and colonic hyperplasia in mice (42) . EspG encoded by C. rodentium shares strong homology with the EspG of EPEC (43, 44) . EspG, secreted by T3SS, of C. rodentium also binds to human tubulin and induces localized microtubule destruction and stimulates actin stress fi ber formation (45) . Disrupting microtubules in colonocytes by EspG and potentially with EspF, the various cell membrane aquaporin water channels that normally absorb water from the gut are repositioned to the cell cytoplasm, contributing to diarrhea during bacterial infection (46) .
CopN of Chlamydia
The Chlamydiae are Gram-negative, obligate intracellular pathogens that cause a range of human diseases, including genital, ocular, and respiratory infections (47) . They undergo a biphasic developmental cycle involving the infectious elementary body (EB), and the replicative, non-infectious reticulate body (RB) (48) . After entering their target eukaryotic cells, EBs differentiate into RBs and replicate within an endosome-derived membranous vacuole, termed ' inclusion ' (48) . Microtubules play an essential role in the intracellular lifestyle of Chlamydia . Chlamydial inclusions are traffi cked along microtubules toward the minus ends and aggregate at the microtubule organizing center (MTOC) (49, 50) . Disruption of microtubules by nocodazole treatment in Cos-7 cells inhibited the characteristic localization of Chlamydia inclusions. Studies have shown that inclusion body translocation depends on the minus-end-directed microtubule motor complex dyenin (49) .
Even though Chlamydia exploits the microtubule network for traffi cking of inclusions, one of the Chlamydia effectors, CopN, exhibits microtubule destabilization properties (51) . Heterologous expression of CopN in yeast and mammalian cells affected the formation of microtubule structures and blocks cell division (52) . Recently, CopN was shown to directly bind non-polymerized α and β -tubulins but not to polymerized microtubules (53) . CopN can effi ciently inhibit microtubule polymerization but cannot induce depolymerization due to its inability to bind to the polymerized microtubules. On the basis of these observations, it is hypothesized that CopN may act like stathmin and destabilize the microtubules by sequestrating α -and β -tubulins (53) . Chlamydia resides at the MTOC, and the microtubule destabilization property of CopN may disrupt the mitotic spindles, leading to chromosomal segregation defects and inhibition of cytokinesis.
EseG of Edwardsiella tarda
Edwardsiella tarda is an enteric pathogen that causes septicemia of fi sh and gastroenteritis of humans (54) (55) . EseG does not share any homology with other microtubule-destabilizing proteins such as VirA and EspG. However, EseG does share a conserved domain with the SseF and SseG proteins of Salmonella. A microtubule destabilization property has not been demonstrated for SseF or SseG, and these effector proteins play an essential role in the perinuclear localization of Salmonella-containing vacuoles. In fact, SseG co-localizes with microtubules and exhibit microtubule-bundling properties (56) . Nevertheless, the conserved domain is reported to be essential for EseG to destabilize microtubules (55) . EseG interacts with α -tubulin through a separate domain at the N-terminus of the protein (55) . The actual mechanism of EseG-mediated microtubule destruction remains to be elucidated.
ActA of Listeria
Listeria monocytogenes is an intracellular pathogenic bacterium that causes the severe food-borne infection listeriosis (57) . Listeria is capable of invading and replicating in a variety of mammalian cells. After internalization, Listeria prevents phagosome-lysosome fusion and escapes from the phagosome with the help of its virulence protein, LLO (58) . Free bacteria then replicate in the cells and spread to neighboring cells without inducing cell lysis (58 -60) . Listeria encodes a number of virulence factors to facilitate its intracellular survival and spread (61) . Studies have shown that ActA is essential for inter-and intracellular movement of Listeria . ActA induces a comet-shaped actin polymerization at the posterior pole of the bacterium that generates unidirectional propulsion force to push the bacterium through the cytoplasm. ActA mimics the C-terminal domain of WiskottAldrich syndrome protein (WASP) and activates actin-related protein (Arp) 2/3 complex to facilitate the comet formation at the pole of the bacterium (62) . The microtubule-binding protein dynamin-2 co-localizes with the Listeria -induced actin comets. Dynamin-2 is a GTPase protein that is ubiquitously expressed in mammals and plays key roles in various cellular processes, including fi ssion of clathrin-coated endocytic vesicles, vesicle traffi cking, centrosome cohesion, actin reorganization, and microtubule dynamics (63 -67) . Dynamin-2 polymerizes the entire length around the microtubules and contributes to the correct bundling of microtubules. Silencing of dynamin-2 by siRNA results in dynamic instability of microtubules and induces accumulation of acetylated and stable microtubules (68) . Infection of dynamin-2-depleted HeLa cells with Listeria reduces actin comet tail formation and diminishes the speed of bacterial movement (69) . These studies imply that the alteration of microtubule dynamics infl uences the Listeria -induced actin comet tail formation. A number of actin regulatory proteins such as Rho family GTPases are associated with microtubules, and microtubule dynamics regulate actin regulatory protein release and activation (70 -72) . Therefore, alterations of microtubule dynamics likely affect the reorganization of actin cytoskeleton and the formation of actin comets.
A high-throughput yeast two-hybrid screen identifi ed a mammalian protein, LaXp180, that interacts with ActA of Listeria (73) . LaXp180 interacts with a well-characterized microtubule-destabilizing protein, stathmin (74) . Stathmin sequestrates tubulin dimers by forming a complex and reduces the concentration of free tubulin available for polymerization (39, 40, 75) . In addition to the tubulin sequestration, stathmin also promotes microtubule catastrophe or shortening through an unidentifi ed mechanism (75) . The role of microtubules on the intracellular lifestyle of Listeria has not been investigated in detail. However, stathmin-mediated microtubule depletion by Listeria proteins may lead to actin rearrangement that promotes bacterial movement and spread. Studies have shown that the microtubule destabilization property of stathmin is inactivated by its phosphorylation, and the phosphorylated stathmin induces lamellipodia formation that is mediated by a multiprotein complex termed WAVE-2 (76, 77) . Whether the ActA-LaXp180-stathmin interaction induces lamellipodia formation to promote the spread of Listeria is an area that needs to be addressed.
Stabilization of host microtubule cytoskeleton by bacterial pathogens
Many invasive and adherent bacterial pathogens induce stabilization of host microtubules to promote their survival and persistence (Figure 2 ) . The mechanism by which bacterial effector proteins induce the stabilization of host microtubules and the benefi cial role of stabilized microtubules for survival of certain pathogens in the host are poorly understood. Major bacterial effector proteins that stabilize host microtubules are as follows.
SifA of Salmonella
Salmonellae are gastrointestinal pathogens causing diseases ranging from enteritis to typhoid fever (78) . They are facultative intracellular pathogens and reside in membranous compartments termed Salmonella -containing vacuoles (SCV). Salmonella possess two T3SS to deliver its effector proteins to the host cytosol to modify the host cell processes to benefi t the pathogen. The Salmonella-secreted proteins SifA, SseF, and SseG have been reported to affect microtubule dynamics (56) . SifA is an important virulence protein of Salmonella and induces tubular networks, termed as Salmonella -induced fi laments (SIFs), that extend from the SCVs (79) . SIF formation is essential for pathogenicity as the SifA mutant Salmonella presents an attenuated phenotype in mice and macrophages (80, 81) . Intact microtubules are required for the formation of SIFs, indicating that SIF structures are formed on the scaffolding of microtubules (56, 79) . Recent studies have shown that SIFs constitute the tubular aggregates of phagosomes, and the tubular networks require the participation of host SifA kinesin-interacting protein, SKIP, and the microtubule motor, kinesin-1 (82, 83) . The Salmonella effectors SseG and SseF interfere with microtubule organization and induce massive microtubule bundling (56) . It is hypothesized that microtubule reorganization may reduce or block the vesicles that transport along the microtubules. Therefore, microtubule bundling may bring the vesicles in close proximity, leading to their fusion and formation of tubular networks along the microtubules (56) benefi ting the Salmonella . The mechanism by which these Salmonella effectors alter the microtubule organization remains obscure.
TcpB of Brucella spp.
Brucella spp. are infectious intracellular pathogens causing brucellosis of animals and humans (84) . Brucella spp. encode a Toll/interleukin-like receptor domain (TIR domain)-containing protein termed TcpB/Bpt1. TcpB harbors a phosphoinositidebinding domain at the N-terminus and a TIR domain at the C-terminus (85) . TcpB inhibits host innate immune responses meditated by TLR2 and TLR4 (85 -87) . Recent studies have shown that TcpB targets a TLR adaptor protein, TIRAP, to inhibit TLRs by inducing the ubiquitination and degradation of TIRAP (85, 88) . Overexpression of TcpB in mammalian cells resulted in dramatic cell shrinkage and rounding up, suggesting a potential interaction with microtubules of the cell. Subcellular localization studies indicate that TcpB co-localizes predominantly with the microtubules (Figure 3 ) (85) . Microtubule localization is attributed to the TIR domain of TcpB and a point mutation at the active site of TIR domain, i.e., BB-loop, abolished the affi nity for microtubules. TcpBexpressing cells display thickened and bundled microtubule networks indicative of microtubule stabilization.
Polymerization of microtubules in the presence of purifi ed TcpB reveals a robust microtubule stabilization property of TcpB. TcpB acts like the microtubule-stabilizing drug paclitaxel, and dramatically enhances the nucleation and growth phases of microtubule polymerization (Figure 4 ) (89) . In addition, TcpB can effi ciently suppress the inhibition of microtubule depolymerization by nocodazole or cold. In agreement with the subcellular localization studies, a BB-loop mutant TcpB exhibits defective microtubule binding and stabilization properties (89) .
The signifi cance of TcpB-microtubule interaction and microtubule stabilization remains obscure. Potentially, TcpB induces microtubule bundling to interfere with the vesicular transport along microtubule tracks that may benefi t Brucellae to prevent phagosome-lysosome fusion and subsequent phagosomal killing. However, experiments to demonstrate the secretion of TcpB by Brucella have not yet been successful. As the intact BB-loop is crucial for both microtubule stabilization as well as TLR inhibition, a correlation between these two properties has also been hypothesized. Nevertheless, the role of microtubules in the regulation of TLR signaling remains enigmatic. Studies are in progress to address the signifi cance and mechanism of TcpB-induced microtubule stabilization.
CDT toxin of Clostridium diffi cile
Clostridium diffi cile is a major cause of chronic antibioticassociated diarrhea and pseudomembranous colitis (90) . Hypervirulent strains of C. diffi cile produce the binary actin-ADP ribosylating toxin, C. diffi cile transferase (CDT). CDT depolymerizes the actin cytoskeleton using its actin-modifying ADP-ribosyltransferase property. Expression of CDT in the human colon carcinoma cell line Caco-2 induced characteristic cell surface projections that consist of microtubules (91) . Subsequent analyses indicate that in the presence of CDT, microtubules form bundles and grow along the cell cortex and project from the cell surface. The microtubules that cross the cell borders are capped with a microtubule plusend-tracking protein, EB1, indicating that microtubule protrusions are the result of tubulin polymerization rather than sliding of microtubules. In addition, CDT causes redistribution of microtubule-capturing proteins, CLASP2 and ACF7, from the cell periphery to the cell interior (91) . The capture of growing microtubules at the cell cortex by tip-associated proteins is an important process that regulates microtubule dynamics (92, 93) . Interfering with this capturing process by CDT may contribute to the growth of microtubules beyond the cell borders. Induction of microtubule-derived cell protrusions increase adherence and colonization of Clostridia on epithelial cells (91) . The iota toxin of Clostridium perfringes and C2 toxin of Clostridium botulinum also induce microtubule-based protrusions on the surface of epithelial cells (91) .
Pneumolysin of Streptococcus pneumonia
Streptococcus pneumoniae is a major causative agent of bacterial meningitis (94) . Streptococcus pneumoniae encodes pneumolysin (Ply), a member of the cholesterol-dependent cytolysins that is essential for the virulence of the bacteria (95, 96) . Microtubule stabilization is observed in pneumococcal meningitis and is attributed to the pneumolysin of S. pneumoniae (97) . The expression of sublytic levels of pneumolysin in SH-SY5Y neuron cells induces massive micro tubule bundling and increased levels of acetylated tubulin and stabilized microtubules (97) . Ply-induced microtubule bundling is partially affected by the addition of Src-kinase family inhibitors. As members of the tyrosine kinase family are known to promote tubulin polymerization and stabilize microtubules, Ply-mediated microtubule stabilization is thought to be mediated by tyrosine kinases (97 -99) . Plymediated microtubule stability and bundling inhibits organelle transport as demonstrated for defective mitochondrial transport in Chinese hamster ovary cells (97) . Therefore, defective organelle transport caused by microtubule stabilization may explain the neuronal dysfunction in the course of pneumococcal meningitis. Streptococcus pneumoniae is not a classic intracellular pathogen; however, it is capable of invading and propagating in host cells (100, 101) . Therefore, Plyinduced microtubule stabilization may help the intracellular survival of the bacterium by interfering with the vesicular transport and inhibiting phagosome killing. Despite extensive research in the fi eld of host-pathogen interaction, the mechanism of action of many of the above-discussed effector proteins remains to be elucidated. Therefore, future studies need to address various effector protein strategies that modulate the host microtubule dynamics and its contribution to the survival and persistence of bacterial pathogens in the host. Insights into the effector protein-microtubule interaction will undoubtedly provide an opportunity to develop innovative therapeutic strategies, such as antivirulence drugs that inhibit the specifi c functions of the effector protein. Future research should also focus on identifying novel virulence proteins of pathogenic microorganisms that target the organization of host microtubule networks.
Conclusion
Microtubules are easy targets of pathogenic microorganisms for hijacking the cellular processes to create a replicationpermissive niche. Modulation of microtubule dynamics benefi ts the pathogen in various ways, including promoting intracellular motility, interfering with vesicular traffi cking, and reorganizing the actin cytoskeleton. Therefore, detailed studies on microtubule-pathogen interaction will undoubtedly contribute to our understanding of pathogenicity and host adaptation of several infectious pathogens. Additionally, the virulence proteins that affect microtubule dynamics constitute a handy tool for dissecting various cellular processes that are regulated by microtubules. Similar studies will also provide valuable insight into the infl uence of microtubules on the dynamics of the actin cytoskeleton.
